Study of a fixed dose of Rekovelle for IUI treatment
Part of Women’s health & pregnancy clinical trials.
This trial tests a fixed dose of the hormone follitropin delta (Rekovelle) to stimulate the ovaries before intrauterine insemination (IUI). It aims to see if this approach works well for women with regular cycles who are starting IUI for the first time.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have regular menstrual cycles (monthly periods)
- You are between 18 and 38 years old
- Your body mass index (BMI) is between 18 and 29
- You have at least one fallopian tube that is open and healthy
- You have a normal-shaped uterus
- You have not had IUI treatment before
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how follitropin delta is used in real clinics to help women stimulate eggs for IVF or ICSI. It may help doctors fine-tune dosing by comparing outcomes in everyday practice.
This trial compares a generic version of cetrorelix acetate (a medication used to control ovulation) to the brand-name version during IVF. It aims to see if the generic works just as well for women undergoing ovarian stimulation.
This trial tests whether taking progesterone after a type of fertility treatment called IUI can improve success rates. The study focuses on people who are using a drug called letrozole to stimulate the ovaries.
This trial tests a fertility drug called follitropin delta for women undergoing IVF. It checks if using this drug with a specific hormone-lowering protocol helps produce eggs for fertilisation.
This study tests a one-time injection medicine (corifollitropin alfa) to help older women produce eggs for IVF. It aims to see if this medicine is safe and works well for women aged 36 to 40 with normal ovarian function.
This study tests whether adding a hormone called r-hLH to standard IVF treatment helps women aged 35 to 40 produce better eggs and improve their chances of pregnancy. It is for women who are on their first or second cycle of assisted reproduction.
Hear when a new Infertility trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.